SAVANNAH POINTER: Open Payments
NPI 1215785134 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $236 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $232 |
| Dexcom, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $35 |
| Exact Sciences Corporation | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Wegovy, Dexcom G6 Transmitter, REXULTI, Ozempic, Cologuard Collection Kit, VRAYLAR, VOQUEZNA, CAPLYTA.
Industry payments across AL — which companies pay providers there.
